Literature DB >> 18228243

Rapid and sensitive analysis of vincristine in human plasma using on-line extraction combined with liquid chromatography/tandem mass spectrometry.

Giuseppe Corona1, Bruno Casetta, Sara Sandron, Emanuela Vaccher, Giuseppe Toffoli.   

Abstract

A simple and rapid method has been developed and validated for the quantitation of vincristine in human plasma by liquid chromatography/tandem mass spectrometry (LC/MS/MS) with atmospheric pressure chemical ionization using on-line solid-phase extraction. The method uses vinblastine as internal standard and the sample preparation is limited just to a plasma protein precipitation step. Further sample clean-up is carried out on-line through a perfusion column preceding an analytical phenyl LC column, the latter directly connected to the mass spectrometer. Quantitation is performed in multiple reaction monitoring mode using the transitions of m/z 825.3 --> 765.3 and 811.3 --> 751.3 for vincristine and vinblastine respectively. The assay was linear (r2 > or =0.99) in a concentration range from 0.1 to 500 ng/mL. Carry-over, measured on the experimental set-up, was less than 0.04%. Recovery for vincristine and the internal standard was within 90-95%. The intra-day and inter-day assay precision ranged from 1.2% to 6.8% RSD while mean percentage deviation from nominal value ranged from 0.01% to 6.1%. The proposed assay was found suitable for pharmacokinetics investigations and clinical therapeutic drug monitoring especially in pediatric cancer patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18228243     DOI: 10.1002/rcm.3390

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.

Authors:  Till Milde; Susanne Kleber; Andrey Korshunov; Hendrik Witt; Thomas Hielscher; Philipp Koch; Hans-Georg Kopp; Manfred Jugold; Hedwig E Deubzer; Ina Oehme; Marco Lodrini; Hermann-Josef Gröne; Axel Benner; Oliver Brüstle; Richard J Gilbertson; Andreas von Deimling; Andreas E Kulozik; Stefan M Pfister; Ana Martin-Villalba; Olaf Witt
Journal:  Acta Neuropathol       Date:  2011-08-24       Impact factor: 17.088

2.  Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.

Authors:  Purvaba J Sarvaiya; Jason R Schwartz; Claudia P Hernandez; Paulo C Rodriguez; Wayne V Vedeckis
Journal:  Am J Hematol       Date:  2012-07-05       Impact factor: 10.047

3.  Schwann cell autophagy induced by SAHA, 17-AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy.

Authors:  T Watanabe; K Nagase; M Chosa; K Tobinai
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

4.  Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.

Authors:  Rachel M A Linger; Deborah DeRyckere; Luis Brandão; Kelly K Sawczyn; Kristen M Jacobsen; Xiayuan Liang; Amy K Keating; Douglas K Graham
Journal:  Blood       Date:  2009-07-30       Impact factor: 22.113

5.  Clinical pharmacokinetics and effects of vincristine sulfate in dogs with transmissible venereal tumor (TVT).

Authors:  Supannika Hantrakul; Narumol Klangkaew; Sunee Kunakornsawat; Tawewan Tansatit; Ammart Poapolathep; Susumu Kumagai; Saranya Poapolathep
Journal:  J Vet Med Sci       Date:  2014-08-21       Impact factor: 1.267

6.  Rapid quantification of vincristine in mouse plasma using ESI-LC-MS/MS: Application to pharmacokinetic studies.

Authors:  Yan Jin; Yang Li; Muhammad Erfan Uddin; Alex Sparreboom; Shuiying Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2021-02-21       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.